Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Aug;64(8):3236–3243. doi: 10.1128/iai.64.8.3236-3243.1996

Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila.

S J Skerrett 1, T R Martin 1
PMCID: PMC174213  PMID: 8757859

Abstract

Legionella pneumophila is an intracellular parasite of alveolar macrophages, and recovery from legionellosis is associated with activation of alveolar macrophages to resist intracellular bacterial replication. Gamma interferon (IFN-gamma) is known to activate alveolar macrophages to suppress L. pneumophila, but the role of macrophage-derived cytokines in modulating alveolar macrophage resistance is unknown. To test the hypothesis that macrophage-derived mediators contribute to the resistance of alveolar macrophages to L. pneumophila, we incubated adherent rat alveolar macrophages with Escherichia coli lipopolysaccharide (LPS), recombinant tumor necrosis factor alpha (TNF-alpha), recombinant IFN-gamma, neutralizing anti-TNF-alpha, and/or N(G)-monomethyl-L-arginine (L-NMMA) for 6 h before challenge with L. pneumophila. Monolayers were sonically disrupted and quantitatively cultured on successive days. We also measured bioactive TNF-alpha release by infected macrophages in the presence or absence of IFN-gamma. We found that pretreatment of alveolar macrophages with LPS or, to a lesser degree, TNF-alpha, significantly inhibited intracellular replication of L. pneumophila. Both LPS and TNF-alpha acted synergistically with IFN-gamma at less than the maximally activating concentration to suppress L. pneumophila growth. The independent and coactivating effects of LPS were blocked by anti-TNF-alpha. Killing of L. pneumophila by IFN-gamma at the maximally activating concentration was inhibited by anti-TNF-alpha. The synergistic effects of TNF-alpha. or LPS in combination with IFN-gamma were inhibited by L-NMMA. Infected alveolar macrophages secreted TNF-alpha in proportion to the bacterial inoculum, and secretion of TNF-alpha was potentiated by cocultivation with IFN-gamma. These data indicate that secretion of TNF-alpha is an important autocrine defense mechanism of alveolar macrophages, serving to potentiate the activating effects of IFN-gamma through costimulation of nitric oxide synthesis.

Full Text

The Full Text of this article is available as a PDF (256.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albina J. E. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol. 1995 Dec;58(6):643–649. doi: 10.1002/jlb.58.6.643. [DOI] [PubMed] [Google Scholar]
  2. Anthony L. S., Morrissey P. J., Nano F. E. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. J Immunol. 1992 Mar 15;148(6):1829–1834. [PubMed] [Google Scholar]
  3. Arata S., Kasai N., Klein T. W., Friedman H. Legionella pneumophila growth restriction and cytokine production by murine macrophages activated by a novel Pseudomonas lipid A. Infect Immun. 1994 Feb;62(2):729–732. doi: 10.1128/iai.62.2.729-732.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Arata S., Newton C., Klein T. W., Friedman H. Legionella pneumophila growth restriction in permissive macrophages cocultured with nonpermissive lipopolysaccharide-activated macrophages. Infect Immun. 1993 Dec;61(12):5056–5061. doi: 10.1128/iai.61.12.5056-5061.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Arata S., Newton C., Klein T. W., Yamamoto Y., Friedman H. Legionella pneumophila induced tumor necrosis factor production in permissive versus nonpermissive macrophages. Proc Soc Exp Biol Med. 1993 May;203(1):26–29. doi: 10.3181/00379727-203-43568. [DOI] [PubMed] [Google Scholar]
  6. Bermudez L. E., Young L. S. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol. 1988 May 1;140(9):3006–3013. [PubMed] [Google Scholar]
  7. Beutler B., Krochin N., Milsark I. W., Luedke C., Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science. 1986 May 23;232(4753):977–980. doi: 10.1126/science.3754653. [DOI] [PubMed] [Google Scholar]
  8. Bhaskaran G., Nii A., Sone S., Ogura T. Differential effects of interleukin-4 on superoxide anion production by human alveolar macrophages stimulated with lipopolysaccharide and interferon-gamma. J Leukoc Biol. 1992 Aug;52(2):218–223. doi: 10.1002/jlb.52.2.218. [DOI] [PubMed] [Google Scholar]
  9. Blanchard D. K., Djeu J. Y., Klein T. W., Friedman H., Stewart W. E., 2nd Induction of tumor necrosis factor by Legionella pneumophila. Infect Immun. 1987 Feb;55(2):433–437. doi: 10.1128/iai.55.2.433-437.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Blanchard D. K., Djeu J. Y., Klein T. W., Friedman H., Stewart W. E., 2nd Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukoc Biol. 1988 May;43(5):429–435. doi: 10.1002/jlb.43.5.429. [DOI] [PubMed] [Google Scholar]
  11. Blanchard D. K., Friedman H., Klein T. W., Djeu J. Y. Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukoc Biol. 1989 Jun;45(6):538–545. doi: 10.1002/jlb.45.6.538. [DOI] [PubMed] [Google Scholar]
  12. Brieland J. K., Remick D. G., Freeman P. T., Hurley M. C., Fantone J. C., Engleberg N. C. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide. Infect Immun. 1995 Sep;63(9):3253–3258. doi: 10.1128/iai.63.9.3253-3258.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chang H. R., Grau G. E., Pechère J. C. Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology. 1990 Jan;69(1):33–37. [PMC free article] [PubMed] [Google Scholar]
  14. Chao C. C., Gekker G., Hu S., Peterson P. K. Human microglial cell defense against Toxoplasma gondii. The role of cytokines. J Immunol. 1994 Feb 1;152(3):1246–1252. [PubMed] [Google Scholar]
  15. De Titto E. H., Catterall J. R., Remington J. S. Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi. J Immunol. 1986 Aug 15;137(4):1342–1345. [PubMed] [Google Scholar]
  16. Denis M., Gregg E. O., Ghandirian E. Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. Int J Immunopharmacol. 1990;12(7):721–727. doi: 10.1016/0192-0561(90)90034-k. [DOI] [PubMed] [Google Scholar]
  17. Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin Exp Immunol. 1991 May;84(2):200–206. doi: 10.1111/j.1365-2249.1991.tb08149.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ding A. H., Nathan C. F., Stuehr D. J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988 Oct 1;141(7):2407–2412. [PubMed] [Google Scholar]
  19. Dugas B., Mossalayi M. D., Damais C., Kolb J. P. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today. 1995 Dec;16(12):574–580. doi: 10.1016/0167-5699(95)80080-8. [DOI] [PubMed] [Google Scholar]
  20. Egawa K., Klein T. W., Yamamoto Y., Newton C. A., Friedman H. Enhanced growth restriction of Legionella pneumophila in endotoxin-treated macrophages. Proc Soc Exp Biol Med. 1992 Jul;200(3):338–342. doi: 10.3181/00379727-200-43439. [DOI] [PubMed] [Google Scholar]
  21. Esparza I., Männel D., Ruppel A., Falk W., Krammer P. H. Interferon gamma and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni. J Exp Med. 1987 Aug 1;166(2):589–594. doi: 10.1084/jem.166.2.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Flesch I. E., Hess J. H., Oswald I. P., Kaufmann S. H. Growth inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int Immunol. 1994 May;6(5):693–700. doi: 10.1093/intimm/6.5.693. [DOI] [PubMed] [Google Scholar]
  23. Flesch I. E., Kaufmann S. H. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immun. 1990 Aug;58(8):2675–2677. doi: 10.1128/iai.58.8.2675-2677.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gebran S. J., Yamamoto Y., Newton C., Klein T. W., Friedman H. Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect Immun. 1994 Aug;62(8):3197–3205. doi: 10.1128/iai.62.8.3197-3205.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Gebran S. J., Yamamoto Y., Newton C., Tomioka M., Widen R., Klein T. W., Friedman H. LPS inhibits the intracellular growth of Legionella pneumophila in thioglycolate elicited murine peritoneal macrophages by iron-dependent, tryptophan-independent, oxygen-independent, and arginine-independent mechanisms. J Leukoc Biol. 1995 Jan;57(1):80–87. doi: 10.1002/jlb.57.1.80. [DOI] [PubMed] [Google Scholar]
  26. Green S. J., Crawford R. M., Hockmeyer J. T., Meltzer M. S., Nacy C. A. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J Immunol. 1990 Dec 15;145(12):4290–4297. [PubMed] [Google Scholar]
  27. Hirsch C. S., Ellner J. J., Russell D. G., Rich E. A. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol. 1994 Jan 15;152(2):743–753. [PubMed] [Google Scholar]
  28. Ho J. L., He S. H., Rios M. J., Wick E. A. Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. J Infect Dis. 1992 Feb;165(2):344–351. doi: 10.1093/infdis/165.2.344. [DOI] [PubMed] [Google Scholar]
  29. Horwitz M. A. Cell-mediated immunity in Legionnaires' disease. J Clin Invest. 1983 Jun;71(6):1686–1697. doi: 10.1172/JCI110923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Jacobs R. F., Locksley R. M., Wilson C. B., Haas J. E., Klebanoff S. J. Interaction of primate alveolar macrophages and Legionella pneumophila. J Clin Invest. 1984 Jun;73(6):1515–1523. doi: 10.1172/JCI111357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jensen W. A., Rose R. M., Burke R. H., Jr, Anton K., Remold H. G. Cytokine activation of antibacterial activity in human pulmonary macrophages: comparison of recombinant interferon-gamma and granulocyte-macrophage colony-stimulating factor. Cell Immunol. 1988 Dec;117(2):369–377. doi: 10.1016/0008-8749(88)90126-8. [DOI] [PubMed] [Google Scholar]
  32. Jorens P. G., Van Overveld F. J., Bult H., Vermeire P. A., Herman A. G. L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol. 1991 Aug 6;200(2-3):205–209. doi: 10.1016/0014-2999(91)90573-9. [DOI] [PubMed] [Google Scholar]
  33. Kura F., Suzuki K., Watanabe H., Akamatsu Y., Amano F. Difference in Legionella pneumophila growth permissiveness between J774.1 murine macrophage-like JA-4 cells and lipopolysaccharide (LPS)-resistant mutant cells, LPS1916, after stimulation with LPS. Infect Immun. 1994 Dec;62(12):5419–5423. doi: 10.1128/iai.62.12.5419-5423.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lane T. E., Wu-Hsieh B. A., Howard D. H. Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect Immun. 1993 Apr;61(4):1468–1473. doi: 10.1128/iai.61.4.1468-1473.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Langermans J. A., Van der Hulst M. E., Nibbering P. H., Hiemstra P. S., Fransen L., Van Furth R. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. J Immunol. 1992 Jan 15;148(2):568–574. [PubMed] [Google Scholar]
  36. Liew F. Y., Li Y., Millott S. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol. 1990 Dec 15;145(12):4306–4310. [PubMed] [Google Scholar]
  37. Locksley R. M., Jacobs R. F., Wilson C. B., Weaver W. M., Klebanoff S. J. Susceptibility of Legionella pneumophila to oxygen-dependent microbicidal systems. J Immunol. 1982 Nov;129(5):2192–2197. [PubMed] [Google Scholar]
  38. Martin T. R., Mathison J. C., Tobias P. S., Letúrcq D. J., Moriarty A. M., Maunder R. J., Ulevitch R. J. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J Clin Invest. 1992 Dec;90(6):2209–2219. doi: 10.1172/JCI116106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Matsiota-Bernard P., Léfèbre C., Sedqui M., Cornillet P., Guenounou M. Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes. Infect Immun. 1993 Dec;61(12):4980–4983. doi: 10.1128/iai.61.12.4980-4983.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Meylan P. R., Richman D. D., Kornbluth R. S. Reduced intracellular growth of mycobacteria in human macrophages cultivated at physiologic oxygen pressure. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):947–953. doi: 10.1164/ajrccm/145.4_Pt_1.947. [DOI] [PubMed] [Google Scholar]
  41. Muñoz-Fernández M. A., Fernández M. A., Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett. 1992 Jun;33(1):35–40. doi: 10.1016/0165-2478(92)90090-b. [DOI] [PubMed] [Google Scholar]
  42. Nash T. W., Libby D. M., Horwitz M. A. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. J Immunol. 1988 Jun 1;140(11):3978–3981. [PubMed] [Google Scholar]
  43. Nash T. W., Libby D. M., Horwitz M. A. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J Clin Invest. 1984 Sep;74(3):771–782. doi: 10.1172/JCI111493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992 Sep;6(12):3051–3064. [PubMed] [Google Scholar]
  45. Nathan C., Xie Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994 Sep 23;78(6):915–918. doi: 10.1016/0092-8674(94)90266-6. [DOI] [PubMed] [Google Scholar]
  46. Oswald I. P., Wynn T. A., Sher A., James S. L. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8676–8680. doi: 10.1073/pnas.89.18.8676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Polsinelli T., Meltzer M. S., Fortier A. H. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages. J Immunol. 1994 Aug 1;153(3):1238–1245. [PubMed] [Google Scholar]
  48. Roach T. I., Kiderlen A. F., Blackwell J. M. Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect Immun. 1991 Nov;59(11):3935–3944. doi: 10.1128/iai.59.11.3935-3944.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rose R. M., Fuglestad J. M., Remington L. Growth inhibition of Mycobacterium avium complex in human alveolar macrophages by the combination of recombinant macrophage colony-stimulating factor and interferon-gamma. Am J Respir Cell Mol Biol. 1991 Mar;4(3):248–254. doi: 10.1165/ajrcmb/4.3.248. [DOI] [PubMed] [Google Scholar]
  50. Sibley L. D., Adams L. B., Fukutomi Y., Krahenbuhl J. L. Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages. J Immunol. 1991 Oct 1;147(7):2340–2345. [PubMed] [Google Scholar]
  51. Skerrett S. J., Henderson W. R., Martin T. R. Alveolar macrophage function in rats with severe protein calorie malnutrition. Arachidonic acid metabolism, cytokine release, and antimicrobial activity. J Immunol. 1990 Feb 1;144(3):1052–1061. [PubMed] [Google Scholar]
  52. Skerrett S. J., Martin T. R. Alveolar macrophage activation in experimental legionellosis. J Immunol. 1991 Jul 1;147(1):337–345. [PubMed] [Google Scholar]
  53. Skerrett S. J., Martin T. R. Intratracheal interferon-gamma augments pulmonary defenses in experimental legionellosis. Am J Respir Crit Care Med. 1994 Jan;149(1):50–58. doi: 10.1164/ajrccm.149.1.8111597. [DOI] [PubMed] [Google Scholar]
  54. Skerrett S. J., Martin T. R. Recombinant murine interferon-gamma reversibly activates rat alveolar macrophages to kill Legionella pneumophila. J Infect Dis. 1992 Dec;166(6):1354–1361. doi: 10.1093/infdis/166.6.1354. [DOI] [PubMed] [Google Scholar]
  55. Skerrett S. J., Schmidt R. A., Martin T. R. Impaired clearance of aerosolized Legionella pneumophila in corticosteroid-treated rats: a model of Legionnaires' disease in the compromised host. J Infect Dis. 1989 Aug;160(2):261–273. doi: 10.1093/infdis/160.2.261. [DOI] [PubMed] [Google Scholar]
  56. Summersgill J. T., Powell L. A., Buster B. L., Miller R. D., Ramirez J. A. Killing of Legionella pneumophila by nitric oxide in gamma-interferon-activated macrophages. J Leukoc Biol. 1992 Dec;52(6):625–629. doi: 10.1002/jlb.52.6.625. [DOI] [PubMed] [Google Scholar]
  57. Suzuki K., Lee W. J., Hashimoto T., Tanaka E., Murayama T., Amitani R., Yamamoto K., Kuze F. Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex. Clin Exp Immunol. 1994 Oct;98(1):169–173. doi: 10.1111/j.1365-2249.1994.tb06625.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Sypek J. P., Jacobson S., Vorys A., Wyler D. J. Comparison of gamma interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages. Infect Immun. 1993 Sep;61(9):3901–3906. doi: 10.1128/iai.61.9.3901-3906.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Theodos C. M., Povinelli L., Molina R., Sherry B., Titus R. G. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect Immun. 1991 Aug;59(8):2839–2842. doi: 10.1128/iai.59.8.2839-2842.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411–452. doi: 10.1146/annurev.iy.10.040192.002211. [DOI] [PubMed] [Google Scholar]
  61. Yamamoto Y., Klein T. W., Newton C. A., Widen R., Friedman H. Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Infect Immun. 1988 Feb;56(2):370–375. doi: 10.1128/iai.56.2.370-375.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Yoshida S., Goto Y., Miyamoto H., Fujio H., Mizuguchi Y. Association of Lps gene with natural resistance of mouse macrophages against Legionella pneumophila. FEMS Microbiol Immunol. 1991 Dec;4(1):51–56. doi: 10.1111/j.1574-6968.1991.tb04970.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES